About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Renter's insurance Business News Labor economy
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags US: News Business Companies
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Weight loss diets Medicine WW International Inc
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Eli Lilly and Co ETF Edge Health & Science
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Stock markets Business News Compagnie Financiere Richemont SA
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Social issues Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags US: News Business Companies
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Biotech and Pharmaceuticals Europe Markets Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Breaking News: Markets Investment strategy Breaking News: Investing
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Business US: News Companies
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Markets Investing stocks
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Breaking news Companies Business
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Europe Politics Deutsche Bank AG UBS Group AG
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Salesforce Inc Earnings Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Markets Reliance Steel & Aluminum Co Alphabet Inc
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags World Markets Daily Open Paramount Global
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Diets and dieting Weight management CNBC Changemakers
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Drug trials Diabetes Weight management
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Health care industry Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Nestle SA Sanofi SA Retail
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Breaking News: Markets Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Obesity Pharmaceuticals Drugs
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags AstraZeneca PLC Eli Lilly and Co Health & Science
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Mergers Business News Novo Nordisk A/S
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Health care industry Novo Nordisk A/S Breaking News: Investing
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Amazon/com Inc United Parcel Service Inc Advanced Micro Devices Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Bayer AG JPMORGAN DRN Pfizer Inc
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.